10
Participants
Start Date
January 12, 2024
Primary Completion Date
February 23, 2024
Study Completion Date
July 31, 2026
Abemaciclib
Administered orally.
Darolutamide
Administered orally.
LHRH agonist/antagonist
Physician's choice. Administered in accordance with the prescribing information.
Instituto Catalan de Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat
Laura and Isaac Perlmutter Cancer Center, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
Universitätsklinikum Schleswig-Holstein, Lübeck
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Virgen Del Rocio, Seville
Studienpraxis Urologie, Nürtingen
Highlands Oncology Group, Springdale
Klinikum Rechts Der Isar Der Technischen Universität München, Munich
Hospital Infanta Cristina, Badajoz
Collaborators (1)
Bayer
INDUSTRY
Eli Lilly and Company
INDUSTRY